The Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s blockbuster weight-loss drug Wegovy that the company said will be available early in the new year. Why it matters: It’s the first oral GLP-1 drug approved for weight loss and could provide a more convenient and cheaper alternative to the injectable version. The 1.5-milligram starting dose will be available in early January for $149 per month, Novo Nordisk…